| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Balakrishnan Brinda is a Director at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $288K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sell | 520 | $5.74 | $2,984.80 | -2.9% | +15.2% | +49.2% |